Hard Shell vs Soft Shell: Which HBOT Chamber Is Right for You?

When people start researching hyperbaric oxygen therapy, the first question is usually about what it does. The second, and often more consequential, question is which type of chamber they should be using.

The distinction between hard shell and soft shell chambers is not just technical. It determines the pressure you can reach, the protocols available to you, and whether a given chamber is appropriate for your specific goals. Getting this wrong is expensive, both in time and money.

Here is what you need to understand before you book a session or consider a purchase.

The Core Difference: Pressure

Everything else flows from this single variable.

Hard shell chambers, also called monoplace or multiplace chambers depending on their design, are rigid, typically constructed from steel or acrylic, and are engineered to operate at pressures of 1.5 ATA and above. Many clinical hard shell chambers reach 2.0 to 3.0 ATA. At these pressures, oxygen dissolves into the plasma at concentrations that produce meaningful physiological effects.

Soft shell chambers are inflatable, constructed from flexible materials, and are generally limited to pressures between 1.3 and 1.5 ATA. Some models are marketed as reaching 1.5 ATA, though real-world performance often falls short of that ceiling.

That pressure gap, roughly 0.5 to 1.5 ATA, is not a minor technical footnote. The amount of oxygen that dissolves into blood plasma increases significantly with pressure. The protocols used for serious clinical applications are calibrated to pressures that most soft shell chambers simply cannot reach.

What Hard Shell Chambers Are Used For

Hard shell chambers are the standard in clinical and hospital-based HBOT. They are used for conditions where the evidence base is strongest and where precise, repeatable pressure delivery matters.

These include wound healing in diabetic patients, decompression sickness, carbon monoxide poisoning, radiation tissue damage, and a range of other indications that have been studied extensively at specific pressure and duration parameters.

When a physician prescribes HBOT, they are prescribing a protocol, a specific pressure, duration, and number of sessions, that has been validated in clinical research. That research was almost universally conducted in hard shell chambers at pressures of 2.0 ATA or higher.

Hard shell chambers also allow for precise oxygen delivery. In a monoplace chamber, the entire environment is pressurised with oxygen. In a multiplace chamber, patients breathe 100% oxygen through a mask or hood while the chamber itself is pressurised with air. Both approaches deliver far higher dissolved oxygen concentrations than a soft shell chamber can achieve.

What Soft Shell Chambers Are Used For

Soft shell chambers occupy a different space. They are more accessible, more portable, and considerably less expensive than hard shell alternatives. For home use, they are often the only practical option.

At 1.3 to 1.5 ATA, soft shell chambers can produce mild increases in dissolved oxygen. Some users report benefits for general wellness, recovery from training, jet lag, and fatigue. These are areas where the evidence is less formalised, but where anecdotal experience is substantial.

For athletes using HBOT as a recovery tool between training sessions, a soft shell chamber at home can be a practical complement to periodic hard shell sessions at a clinic. The two are not mutually exclusive.

What soft shell chambers are not suitable for is replacing clinical HBOT for conditions that require higher pressures. Using a 1.3 ATA soft shell chamber as a substitute for a prescribed 2.4 ATA protocol is not a meaningful approximation. The physiological effects at those pressures are categorically different.

Compliance, Safety Standards, and Why They Matter

This is the part of the conversation that does not appear in most chamber marketing materials, and it is arguably the most important.

Soft shell chambers are not FDA cleared for medical use

Soft shell hyperbaric chambers are not cleared by the FDA as medical devices for the treatment of any condition. They are typically sold as wellness products. This distinction has real consequences. It means there is no regulatory requirement for the manufacturer to demonstrate clinical efficacy, no mandated safety testing to the standards applied to medical devices, and no requirement for physician oversight in their use.

Some soft shell chambers are marketed with language that implies clinical equivalence to hard shell HBOT. That language is not supported by the regulatory record. Purchasing a soft shell chamber in the belief that it delivers the same therapeutic effect as a clinically prescribed hard shell protocol is a misunderstanding the market actively encourages.

PVHO compliance and why it is not optional for hard shell chambers

Hard shell hyperbaric chambers that are used clinically are subject to PVHO standards, specifically PVHO 1 (Safety Standard for Pressure Vessels for Human Occupancy) published by the American Society of Mechanical Engineers. PVHO 1 governs the design, fabrication, inspection, testing, and maintenance of chambers in which a person is enclosed under pressure.

A hard shell chamber that does not meet PVHO 1 requirements is not a compliant clinical device. It is a pressure vessel of unknown engineering integrity being used to enclose a human being. The consequences of a structural failure under pressure are severe.

PVHO compliance is not a marketing credential. It is a baseline engineering and safety requirement. When evaluating any hard shell chamber, whether for a clinic, a wellness facility, or personal use, PVHO 1 certification should be a non-negotiable starting point, not an optional feature.

Non-compliant hard shell chambers carry the same risks

It would be a mistake to assume that any hard shell chamber is automatically safer than a soft shell chamber. A hard shell chamber that has not been designed, fabricated, and maintained to PVHO 1 standards carries structural and operational risks that a compliant chamber does not. Non-compliant hard shell chambers exist in the market, particularly in the secondhand and import categories, and they should be approached with the same caution as any unregulated pressure vessel.

The compliance question applies equally to both chamber types. Neither a non-compliant hard shell chamber nor an uncleared soft shell chamber should be treated as a safe or appropriate substitute for a properly certified clinical device.

What this means in practice

If you are considering any chamber purchase, the compliance status of that chamber is a foundational question, not a secondary one. For hard shell chambers, PVHO 1 certification and FDA clearance for the intended use are the relevant benchmarks. For soft shell chambers, the honest answer is that no soft shell chamber currently meets those standards for clinical use, and any purchasing decision should be made with that clearly understood.

This is not a reason to dismiss soft shell chambers entirely for the wellness and recovery applications where they are genuinely used. It is a reason to be precise about what they are, what they are not, and what the regulatory and safety picture actually looks like before committing to a purchase.

One detail that is frequently misunderstood: most soft shell chambers are pressurised with ambient air, not pure oxygen. Some models allow for an oxygen concentrator to be connected, which increases the fraction of inspired oxygen, but even then, the combination of lower pressure and lower oxygen concentration produces a very different environment than a hard shell clinical chamber.

When you see marketing materials for soft shell chambers that reference HBOT, it is worth reading carefully. Pressurising a flexible chamber with air to 1.3 ATA is technically hyperbaric, but it is a significant distance from the clinical protocols that most of the research literature describes.

This is not to say soft shell chambers have no value. It is to say that the value they offer is different, and that understanding that difference protects you from misaligned expectations.

Cost and Accessibility

Hard shell chambers are expensive to purchase and operate. A clinical-grade monoplace chamber costs in the range of $100,000 to $200,000 or more. Multiplace chambers are higher still. This is why hard shell HBOT is accessed through clinics, hospitals, and specialist centres rather than at home.

Session costs at a reputable hard shell clinic typically range from $150 to $400 per session, with significant variation depending on location, equipment, and the level of clinical oversight provided.

Soft shell chambers for home use range from approximately $4,000 to $25,000 depending on size, pressure rating, and brand. The ongoing cost is primarily the oxygen concentrator if one is used, plus maintenance.

How to Think About the Decision

The right starting point is your goal, not the chamber.

If you are pursuing HBOT for a specific clinical indication, wound healing, neurological recovery, radiation damage, you need a hard shell chamber at an appropriate clinical pressure, under medical supervision. There is no soft shell equivalent for this use case.

If you are exploring HBOT for general wellness, recovery optimisation, or performance support, a soft shell chamber at home may be a reasonable starting point, potentially combined with periodic hard shell sessions at a clinic for higher-pressure protocols.

If you are considering purchasing a chamber, for personal use, for a wellness facility, or for a clinical practice, the decision involves far more than the chamber itself. It involves the regulatory environment in your jurisdiction, the clinical oversight requirements, the maintenance obligations, the compliance status of the specific device, and the protocols you intend to run.

These are decisions worth getting right the first time. The cost of a poorly matched chamber is substantial, and that cost is not only financial. A non-compliant chamber, whether hard shell or soft shell, introduces risks that a compliant device is specifically engineered to avoid.

A Note on Independent Guidance

The chamber market is not short of salespeople. Manufacturers and distributors have a natural interest in presenting their products favourably, and the marketing language around HBOT can be difficult to parse without a working knowledge of the underlying science.

Independent guidance from someone with no commercial interest in which chamber you choose is genuinely useful here. Understanding what you actually need before you engage with vendors changes the conversation entirely.